pharma manufacturing

Iran Conflict Disrupts India’s Pharma Exports, $500M at Risk A large pill with the Indian flag, an arrow indicating a $500M loss, and a storm below a cracked road.

A large pill with the Indian flag, an arrow indicating a $500M loss, and a storm below a cracked road.

Iran Conflict Disrupts India’s Pharma Exports, $500M at Risk

sivam March 5, 2026

The Iran conflict threatens India's pharmaceutical exports, potentially costing $500 million. Increased freight costs and shipping disruptions...

India Pharma Exports at Risk: Middle East Conflict Impact A map of the Middle East and surrounding regions with a downward trending graph, illustrating the impact on pharma exports.

A map of the Middle East and surrounding regions with a downward trending graph, illustrating the impact on pharma exports.

India Pharma Exports at Risk: Middle East Conflict Impact

sivam March 5, 2026

Escalating Middle East conflict threatens India's pharma exports. Expect shipping delays, higher costs, and supply chain disruptions...

Glenmark’s Fluticasone Inhaler Approved by US FDA A modern fluticasone inhaler with Glenmark branding, glowing medical graphics, and a "US FDA APPROVED" label, against a blurred pharmaceutical manufacturing background.

A modern fluticasone inhaler with Glenmark branding, glowing medical graphics, and a "US FDA APPROVED" label, against a blurred pharmaceutical manufacturing background.

Glenmark’s Fluticasone Inhaler Approved by US FDA

sivam March 4, 2026

Glenmark Pharmaceuticals secures US FDA approval for its fluticasone propionate inhaler. This strategic move strengthens their respiratory...

ZYOG1: The Oral GLP-1 That India Couldn’t Launch Conceptual image showing a modern GLP-1 device and a DNA helix transitioning to a dilapidated factory with 'INDIA' written on it.

Conceptual image showing a modern GLP-1 device and a DNA helix transitioning to a dilapidated factory with 'INDIA' written on it.

ZYOG1: The Oral GLP-1 That India Couldn’t Launch

sivam March 3, 2026

Discover the story of ZYOG1, Zydus's pioneering oral GLP-1 agonist for diabetes and weight loss. Learn about...

AIIMS Milestone: Child Hears After Brain Stem Implant A surgeon's hands delicately hold a brain stem implant near a child's ear, with medical monitors in the background.

A surgeon's hands delicately hold a brain stem implant near a child's ear, with medical monitors in the background.

AIIMS Milestone: Child Hears After Brain Stem Implant

sivam March 3, 2026

AIIMS achieves a medical breakthrough! A young boy in India can hear again after a brain stem...

India’s Dengue Vaccine: Final Trials Bring Hope A dengue vaccine vial in a lab with researchers, symbolizing medical progress and hope.

India’s Dengue Vaccine: Final Trials Bring Hope

sivam February 27, 2026

India's DengiAll vaccine is in final trials, offering a potential single-dose solution against dengue fever. Learn about...

OneDose: Hinckley Medical Rebrands for Strategic Growth Robotic arms oversee a modern pharmaceutical production line, symbolizing Hinckley Medical's rebrand to OneDose.

Robotic arms oversee a modern pharmaceutical production line, symbolizing Hinckley Medical's rebrand to OneDose.

OneDose: Hinckley Medical Rebrands for Strategic Growth

sivam February 26, 2026

Hinckley Medical, a leader in medical devices and pharma manufacturing, rebrands to OneDose. This strategic move, reported...

Alembic Pharma Gets USFDA Approval for Generic Seizure Drug A professional image showing pharmaceutical bottles, a lab flask, and the USFDA logo, set against a blurred manufacturing facility.

Alembic Pharma Gets USFDA Approval for Generic Seizure Drug

sivam February 26, 2026

Alembic Pharmaceuticals receives USFDA approval for Lamotrigine, a generic seizure medication (Lamictal). This offers a more affordable...

Zydus to Launch Generic Semaglutide in Reusable Pen for Diabetes & Obesity Zydus Glycosmart reusable pen and packaging on lab bench

Zydus to Launch Generic Semaglutide in Reusable Pen for Diabetes & Obesity

sivam February 25, 2026

Zydus Lifesciences to launch generic semaglutide (Semaglyn, Mashema, Altreme) in a reusable pen for Type 2 diabetes...

Merck Restructures for Cancer Focus & Growth Amidst Patent Challenges A professional image showing scientific research with DNA strands, cells, and scientists, representing Merck's strategic shift.